Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorders. The main clinical respiratory function tests include diagnosis, assessment of severity, monitoring treatment and evaluation of prognosis. Many physicians opt for blood gases to evaluate oxygen and carbon dioxide levels, lung or pulmonary function tests (PFTs) to help diagnose and monitor lung function, and chest X-rays and or CT (computed tomography) scans to look at lung structure. Majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia.
The global respiratory disease testing market report estimates the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on diagnostic tests such as blood gas tests, imaging tests, lung volume tests, peak flow tests, spirometry tests, CBC and CMP tests along with their end users (clinical laboratories, hospitals and physician office), and forecasts growth trends (CAGR% – 2017 to 2021).
The global respiratory disease testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global respiratory disease testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global respiratory disease testing market and included in this report are CareFusion Corporation, Cosmed, GE Healthcare, ndd Medical Technologies, Inc., Philips Healthcare, and SDI Diagnostics.